Overview

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety and efficacy of a new intravenously administered iron drug to treat anemia in patients on hemodialysis.
Phase:
Phase 3
Details
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Treatments:
Ferrosoferric Oxide
Iron